(Date:11/30/2009)...EW YORK, Nov. 30 The Mi...MJFF) today announced $1.5 million in total awards...lly disease-modifying therapies for Parkinson,s di...proaches to Drug Discovery for Parkinson,s Disease...oration, plc (NYSE: ELN ), a neuroscience-based ...
(Date:11/30/2009)... CHANGCHUN, China and LOS ANGELES, Nov. 30 /PR...uticals, Inc. (OTC Bulletin Board: CYXN; ,China Yo...g manufacturer, distributor and,retailer of pharma...t has,completed preparation for distribution of me... Chinese government recently formalized the nation...
(Date:11/30/2009)...BOSTON and COPENHAGEN, Nov. 30 Exi...oday that the Harvard Medical School ICCB-Longwood...s a MicroRNA Screening Center of Excellence. ICCB...l, and associated hospitals and institutions, for ...Ai libraries. ,, MicroRNAs are a novel class of...
(Date:11/28/2009)... The Vanuatu National Advisory Committe...ional Communication (SNC) Project in collaboration...systems Ltd. of New Zealand have generated prelimi...t will form the background for the country’s...vention on Climate Change (UNFCCC). , ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4...ship Completes CTI,s Transformation to Commercial ... SEATTLE, April 24 Cell Therapeutics, Inc.,(Nasd...ilips, most recently,Vice President and General Ma... President of CTI with direct responsibilities for...ive August 1, 2008. Philips, responsibilities,will...
... April 23 Anadys Pharmaceuticals,Inc. (Nasdaq: A...arter 2008,financial results on Wednesday, April 3... Anadys will hold a conference call and webcast to...and highlights and to provide an update on,its dev...5:00 p.m. Eastern,Daylight Time. A live webcast of...
...iz., April 23 ImaRx Therapeutics,Inc. (Nasdaq: I...agreement,with Abbott Laboratories pursuant to whi...million non-recourse promissory note with Abbott i...ase. As a result, full title to,the urokinase asse...product, all regulatory and clinical documentation...
Other Biology Technology:Veteran Drug Industry Executive to Become President of CTI 2Veteran Drug Industry Executive to Become President of CTI 3Veteran Drug Industry Executive to Become President of CTI 4Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Goat Anti-Mouse Ig + IgM Antibody, FITC Conjugated from Cayman Chemical
CopyControl Induction Solution from EPICENTRE Biotechnologies
RNase III from Ambion
Biology Products: